How to improve cytologic screening for endocervical adenocarcinoma?

European Journal of Gynaecological Oncology

Volumn 23, Issue 6, 2002, Pages 481-485

  Boon, M E ^a   Ouwerkerk Noordam, E ^a   Van Leeuwen, A W F M ^b   Kok, L P ^c   Van Haaften Day, C ^a  

^a LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

^b Laboratory for Pathology   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adenocarcinoma of the endocervix; Bloody; NNS

Indexed keywords

ARTICLE; BLOOD; CANCER DIAGNOSIS; CANCER SCREENING; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROSCOPY; RETROSPECTIVE STUDY; STAINING; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY;

ADENOCARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; NETHERLANDS; NEURAL NETWORKS (COMPUTER); PREDICTIVE VALUE OF TESTS; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036949849     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Boon M. E., Beck S., Kok L. P.: "Semiautomatic PAPNET analysis of proliferating (MiB-1 positive) cells in cervical cytology and histology". Diagn. Cytopathol., 1995, 13, 423.
2. Boon M. E., Kleinschmidt-Guy E. D., Wijsman-Grootendorst A., Hoogeveen M. M.: "Upgrading unsatisfactory cervical smears with the MiB-1 method". Diagn. Cytopathol., 1996, 15, 270.
3. rd ed. Amsterdam - Tokyo. Harwood Academic Publishers, 1996.
4. Hando T., Sugimori H., Higashiiwai H., Kuroshima Y., Nishiya I., Sugimoto O.: "Previous cytology in patients with carcinoma of the cervix". Nippon Sanka Fujinka Gakkai Zasshi, 1986, 38, 1692 (in Japanese).
5. Kim H. S., Underwood D.: "Adenocarcinomas in the cervicovaginal Papanicolaou smear: analysis of a 12-year experience". Diagn. Cytopathol., 1991, 7, 119.
6. Kok M., R., Kok P. G., Boon M. E.: "Potentially difficult smears of women with squamous cell carcinoma pose fewer problems when PAPNET is used for primary screening". Cytopathology, 1999, 10, 324.
7. Krane J. F., Granter S. R., Trask C. E., Hogan C. L., Lee K. R.: "Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases". Cancer, 2001, 93, 8.
8. Kutsuzawa T., Yamada Y., Ishizaki Y., Sato C., Kaneko M., Moriya S., Ichinoe K.: "Reevaluation for overlooked signs of cervical smears in cases of uterine cervical adenocarcinoma". Nippon Sanka Fujinka Gakkai Zasshi, 1984, 36, 2598 (in Japanese).
9. Lee K. R., Minter L. J., Granter S. R.: "Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases". Am. J. Clin. Pathol., 1997, 107, 30.
10. Mitchell H., Medley G.: "Differences between Papanicolaou smears with correct and incorrect diagnoses". Cytopathology, 1995, 6, 368.
11. th European Congress of Cytology, Lillehammer, Norway, 16-19 September 2000..
12. Rosenthal D. L., Mango L. J., Acosta D. A., Peters R. D.: «"Negative" pap smears preceding carcinoma of the cervix: rescreening with the PAPNET system». Am. J. Clin. Pathol., 1993, 100, 331.